A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Circulate Health Secures Strategic Investment from Scrum Ventures to Scale TPE and Microplastics Removal TechnologyHealthradar4. Dezember 2025 What You Should Know: – Circulate Health, a pioneer in Therapeutic Plasma Exchange (TPE) technologies, has secured a seven-figure strategic…
